FDA
Articles tagged with “FDA”
3 articles
FDA Flags Alar's Ketamine Marketing Claims as Risky
The FDA has raised concerns about ketamine marketing claims made by Alar, per an Aug. 31, 2026 Fierce Pharma report. Here's what it means for patients.
Read
news
FDA Ketamine Crackdown: What Patients Should Know
FDA enforcement against illegal ketamine sellers is rising. Learn what this means for patients vetting legitimate telehealth ketamine providers.
news
NRx Gets FDA Expanded Access for Ketamine Protocol
NRx Pharmaceuticals received FDA Expanded Access for its ketamine-based protocol. Here's what this means for patients pursuing treatment for severe depression.
Have a question about this topic?
Use the contact page when you need to send feedback, request a correction, or ask about the resource.